Congressional testimony: occupational exposure and cancer March 6, 1997.
NIOSH 1999 Jun; :1-24
NIOSH presented this testimony at the U.S. Senate Cancer Coalition's March 6, 1997 hearing on future cancer research and policy. Dr. Lawrence Fine presented this testimony on behalf of NIOSH Direct, Dr. Linda Rosenstock. She discusses future directions for research and policy related to cancer and addresses issues surrounding workplace exposure to potential carcinogens. Additionally, she shows how investment in occupational cancer research is an investment in non-occupational cause of cancer with substantial benefit to society.
Carcinogens; Cancer-research; Occupational-exposure; Hazard-evaluation; Epidemiology; Surveillance-programs
EID; DSHEFS; OD
National Institute for Occupational Safety and Health